2022
DOI: 10.3389/fddsv.2022.925825
|View full text |Cite
|
Sign up to set email alerts
|

The challenges and opportunities for the development of COVID-19 therapeutics and preparing for the next pandemic

Abstract: The disease which is today known as COVID-19 is caused by severe acute respiratory. Syndrome coronavirus 2 (SARS-COV-2), was first reported in Wuhan, China in December 2019. The disease has claimed well over six million lives from over 500 million cases. Vaccine hesitancy militates against successful mass vaccination. There is the rapid emergence of new SARS-COV-2 variants, constituting a challenge to the effectiveness of vaccines. Moreover, none of the available vaccines offers 100% protection and even the pr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 85 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?